nalmefene nasal Opvee
Selected indexed studies
- Nalmefene nasal spray (Opvee) for reversal of opioid overdose. (Med Lett Drugs Ther, 2023) [PMID:37871116]
- Treatment of overdose in the synthetic opioid era. (Pharmacol Ther, 2022) [PMID:34637841]
- FDA Approves Nalmefene, a Longer-Lasting Opioid Reversal Nasal Spray. (JAMA, 2023) [PMID:37256577]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Treatment of overdose in the synthetic opioid era. (2022) pubmed
- Nalmefene nasal spray (Opvee) for reversal of opioid overdose. (2023) pubmed
- FDA Approves Nalmefene, a Longer-Lasting Opioid Reversal Nasal Spray. (2023) pubmed
- FDA Approval Summary: Nalmefene Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose. (2025) pubmed
- The Drug Update: Recent drug approvals, summer 2025 edition. (2025) pubmed
- Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride. (2022) pubmed
- Opioid Overdose Reversal With Nalmefene Nasal Spray: A Case Report. (2025) pubmed
- Intranasal Delivery of Medications for the Treatment of Neurologic Conditions: A Pharmacology Update. (2024) pubmed
- The permeation of nalmefene hydrochloride across different regions of ovine nasal mucosa. (2006) pubmed
- Optimizing Absorption for Intranasal Delivery of Drugs Targeting the Central Nervous System Using Alkylsaccharide Permeation Enhancers. (2023) pubmed